Company Page

Enjamb Labs

Founders

Enjamb Labs is a full-stack AI agent platform purpose-built for Biopharma R&D. The platform deploys domain-specialized AI agents across the entire drug program, from preclinical research through clinical trials and regulatory approval, synthesizing clinical evidence, drafting and auditing regulatory documents such as INDs and NDAs, and running statistical programming, all within a single auditable workspace. Backed by Y Combinator (P26), Enjamb integrates with 66 scientific databases and leverages 50-plus fine-tuned models to compress months of drug development work into hours.

Company Founded in 2025